European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunity Immunization 111

European Pharmaceutical Review

JUNE 27, 2023

Immunotherapies can compromise the diversity and complex interactive networks in the microbial ecosystem and therefore play a role in activating or deactivating the patient’s immune response leading to variable outcomes of melanoma treatment. Trials of faecal microbiota transplantation (FMT) have demonstrated proof-of-concept in UC.

Immunity 105

Immunity Immunization Chemotherapy Vaccines 105

Express Pharma

JULY 3, 2023

The Food and Drug Administration (FDA) approved an average of 43 drugs in 2014-18, compared to an average of 23 in the first decade of the century. Many millions of people are vaccinated against COVID-19, thanks to a messenger RNA (mRNA) encapsulated within a lipid nanoparticle.

Biosimilars 95

Biosimilars Drug Development Generic Medicine Diabetes 95

Express Pharma

OCTOBER 9, 2024

He noted that the number of biotech startups has risen from just 50 in 2014 to over 5,000 now, reflecting India’s increasing focus on bioeconomy. He stressed the need for proactive R&D, particularly in developing countermeasures for future pandemics, and the necessity of preparedness through rapid vaccine development.

Vaccines 105

Vaccines Process Improvement Biosimilars Immunity 105

RX Note

APRIL 7, 2024

Consider HPV vaccination. To get rid of them, we have to stimulate the body's own immune system to attack the wart virus. The incubation period can be as long as 12 months. Strategies to reduce risk of transmission include Cover warts when they are being treated. Avoid sharing towels, shoes, or socks. Surgical removal (e.g.

Compounding 52

Compounding Immunity Immunization Community Pharmacies 52

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. Under its cancer therapy products, the company develops low molecular drugs, antibody drugs, cancer peptide vaccines, and diagnostic medicines.

Dosage 56

Dosage Labelling Immunity Immunization 56

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

Diabetes 58

Diabetes Immunity Immunization Pharmaceutical Companies 58